Nov 21, 2019 Will the MORE act make it out of the Senate? By Richard Cheng The MORE Act, introduced in July by House Judiciary Chairman Rep. Jerry Nadler (D-NY), would decriminalize cannabis federally by removing...
Nov 14, 2019 Presenting on Human Genetic Regulations in China By Marco de Morpurgo On 5 November, Xiao Ting, our life sciences and regulatory lawyer based in China, gave a presentation on the recently implemented PRC...
Oct 23, 2019 CBD in the United States By Mark Franklin A super article from our colleagues in the US discussing the use of CBD in food. Since the end of 2018, hemp and hemp products are...
Aug 01, 2019 Digital solutions can help speed up both efficiency and patient outcomes By Victoria Rhodes An app which has recently been trialed at London's Royal Free Hospital has provided clinicians with faster, easy to read results which...
Jul 26, 2019 Opioid addiction - to date largely untreated, but can AI and other tech solutions change all of that? By Victoria Rhodes We are increasingly seeing the digitisation of healthcare - these are just another couple of examples of where start-up companies in the...
Jul 18, 2019 Reflecting on the latest decision by the German pricing regulator on the reimbursement of novel biomarker-based cancer diagnostics By Dr Kokularajah Paheenthararajah Breast cancer is the most common cancer in women. Surgery is the main treatment for early stage breast cancer. To treat a possible but...
Jul 15, 2019 Digital Therapeutics Survey By Mark Franklin DLA Piper, in conjunction with The Lawyer, is compiling a report on Digital Therapeutics, where we are now, what the future holds, the...
Jul 11, 2019 Cannabis Europa By Dylan Kennett Last week was the 2nd annual Cannabis Europa here in London. Over two days there were a number of fantastic discussions around, inter...
Jul 08, 2019 House of Commons Select Committee Reports on Medicinal Cannabis in the UK By Dylan Kennett The House of Commons Select Committee report on medicinal cannabis, published on 3 July 2019, makes a number of recommendations, aimed at...
May 30, 2019 Cannabis news from Spain By Mark Franklin The newspaper article mentions the fact that there is an urgent need of a harmonized regulation for this matter. Also mentions that, in...
May 21, 2019 BioDundee International Conference By Caroline Scott Really looking forward to attending one of the biggest conferences in the life sciences sector in Scotland today - BioDundee. Some hot...
May 14, 2019 Deal or no-deal? UPC Implications following a no-deal Brexit By DLA Piper This week, the UK Government released multiple technical notes detailing the intellectual property implications of a no-deal Brexit for...
May 14, 2019 A more flexible approach to practical completion? By Tom Manley The Court of Appeal has confirmed in the recent case of Mears v Costplan the position that whether practical completion of a construction...
May 13, 2019 R&D spend continues to increase and biotech's share therein becomes larger By Henk Arnold Sijnja US R&D trends show a continued growth in R&D spend and activity. Emerging biopharma companies count for an increasing share of late-stage...
May 07, 2019 Brexit: Implications for the life sciences sector By Caroline Scott Working in the life sciences sector? Worried about how Brexit will impact on your business? As a member of the life sciences team at DLA...
Mar 15, 2019 Reflecting on why we need an International Women's Day By Victoria Rhodes Last Friday was International Women's Day which always brings comments of "when is International Men's Day?" (It's 19 November for those...